<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00575432</url>
  </required_header>
  <id_info>
    <org_study_id>KEK 213/04</org_study_id>
    <secondary_id>1066</secondary_id>
    <nct_id>NCT00575432</nct_id>
  </id_info>
  <brief_title>Evaluation of Kidney Function by Multi-modal Magnetic Resonance Imaging and Spectroscopy</brief_title>
  <official_title>Evaluation of Kidney Function by Multi-modal Magnetic Resonance Imaging and Spectroscopy in Renal Transplantation and Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multimodal functional magnetic resonance (MR) methods, including MR diffusion,
      Blood-Oxygenation Level Dependent (BOLD) imaging and MR spectroscopy may provide
      complementary information about the functional status of a kidney. The researchers
      hypothesize that these non-invasive methods correlate with histology as &quot;gold standard&quot; and
      compete favorably with conventional in part invasive evaluation methods, and thus provide
      specific and early detection of kidney diseases of various etiologies, drug toxicity, or
      renal allograft dysfunction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early and specific detection of dysfunction in kidney diseases and differential diagnosis of
      potential complications in the renal allograft are fundamental to initiate appropriate
      treatment. In addition, determination of renal function may reveal physiological mechanisms
      that may prove useful for future therapeutic procedures. Currently, used methods to access
      renal function like ultrasound, radionuclide imaging, and laboratory methods have several
      disadvantages, as they are nonspecific, require radioactive contrast agents or are limited in
      spatial information. Therefore, alternative non-invasive methods to detect early
      morphological and functional changes are required. Recently, a variety of very promising
      advanced magnetic resonance imaging (MRI) methods have evolved to obtain functional
      information of different organs. These methods include MR angiography, diffusion, perfusion
      and Blood-Oxygenation Level Dependent (BOLD) imaging. In addition to MRI, MR spectroscopy
      (MRS) provides renal functional information. In abdominal organs like the kidney,
      respiratory, and cardiac motion and susceptibility artifacts have limited the use of these
      functional MR methods for clinical applications. However, this may be overcome with the
      advent of greatly enhanced hardware, allowing very fast imaging times. Besides these in vivo
      techniques, novel processing algorithms for complex ex vivo MR spectra of body fluids have
      emerged recently. These methods, labeled &quot;Metabonomics&quot;, access renal function by obtaining
      metabolic profiles that are indicative for renal dysfunction.

      The researchers hypothesize that these non-invasive methods correlate with histology as &quot;gold
      standard&quot; and compete favorably with conventional in part invasive evaluation methods, and
      thus provide specific and early detection of kidney diseases of various etiologies, drug
      toxicity or renal allograft dysfunction.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2004</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of functional MR parameters with histology results as &quot;gold standard&quot; or with final clinical outcome</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation with clinical results, laboratory results (e.g. GFR, serum-creatinine levels), results from other imaging procedures, correlation within MR parameters (e.g. in vivo metabolites vs. in vitro (from urine) metabolites, oxygenation vs. diffusion)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Kidney Transplantation</condition>
  <condition>Urinary Calculi</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>diffusion MRI</intervention_name>
    <description>diffusion MRI</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>BOLD MRI</intervention_name>
    <description>BOLD MRI</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical Outcome</intervention_name>
    <description>Clinical outcome</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Kidney diseases and Renal Allografts
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Minimum age 16 years

          -  Male or female

          -  Signed consensus report to the study

        Exclusion Criteria:

          -  History of allergy to contrast media

          -  Pregnancy

          -  Contraindication for MR examination: Content of electronic devices in the body of the
             subject (i.e. pacemaker of heart, implanted insulin pump, nerve stimulator, or similar
             medical devices), content of metallic foreign bodies or metal-pieces (without amalgam
             filling), claustrophobia

          -  Back or other problems that don't allow motionless lying for 75 minutes

          -  Missing signed consensus report to the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harriet C Thoeny, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Radiology, University of Bern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Vermathen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Bern, Dept.Clinical Research</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter Vermathen, PhD</last_name>
    <phone>0041 31 632 81 74</phone>
    <email>peter.vermathen@insel.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Urology</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beat Roth, MD</last_name>
      <phone>0041 31 632 20 45</phone>
      <email>beat.roth@insel.ch</email>
    </contact>
    <investigator>
      <last_name>Harriet C Thoeny, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Vermathen, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <results_reference>
    <citation>Giannarini G, Kessler TM, Roth B, Vermathen P, Thoeny HC. Functional multiparametric magnetic resonance imaging of the kidneys using blood oxygen level dependent and diffusion-weighted sequences. J Urol. 2014 Aug;192(2):434-9. doi: 10.1016/j.juro.2014.02.048. Epub 2014 Feb 25.</citation>
    <PMID>24582541</PMID>
  </results_reference>
  <results_reference>
    <citation>Eisenberger U, Binser T, Thoeny HC, Boesch C, Frey FJ, Vermathen P. Living renal allograft transplantation: diffusion-weighted MR imaging in longitudinal follow-up of the donated and the remaining kidney. Radiology. 2014 Mar;270(3):800-8. doi: 10.1148/radiol.13122588. Epub 2013 Nov 13.</citation>
    <PMID>24475796</PMID>
  </results_reference>
  <results_reference>
    <citation>Binser T, Thoeny HC, Eisenberger U, Stemmer A, Boesch C, Vermathen P. Comparison of physiological triggering schemes for diffusion-weighted magnetic resonance imaging in kidneys. J Magn Reson Imaging. 2010 May;31(5):1144-50. doi: 10.1002/jmri.22156.</citation>
    <PMID>20432350</PMID>
  </results_reference>
  <results_reference>
    <citation>Eisenberger U, Thoeny HC, Binser T, Gugger M, Frey FJ, Boesch C, Vermathen P. Evaluation of renal allograft function early after transplantation with diffusion-weighted MR imaging. Eur Radiol. 2010 Jun;20(6):1374-83. doi: 10.1007/s00330-009-1679-9. Epub 2009 Dec 16.</citation>
    <PMID>20013274</PMID>
  </results_reference>
  <results_reference>
    <citation>Thoeny HC, Kessler TM, Simon-Zoula S, De Keyzer F, Mohaupt M, Studer UE, Vermathen P. Renal oxygenation changes during acute unilateral ureteral obstruction: assessment with blood oxygen level-dependent mr imaging--initial experience. Radiology. 2008 Jun;247(3):754-61. doi: 10.1148/radiol.2473070877. Epub 2008 Apr 10.</citation>
    <PMID>18403623</PMID>
  </results_reference>
  <results_reference>
    <citation>Thoeny HC, Zumstein D, Simon-Zoula S, Eisenberger U, De Keyzer F, Hofmann L, Vock P, Boesch C, Frey FJ, Vermathen P. Functional evaluation of transplanted kidneys with diffusion-weighted and BOLD MR imaging: initial experience. Radiology. 2006 Dec;241(3):812-21.</citation>
    <PMID>17114628</PMID>
  </results_reference>
  <results_reference>
    <citation>Thoeny HC, Binser T, Roth B, Kessler TM, Vermathen P. Noninvasive assessment of acute ureteral obstruction with diffusion-weighted MR imaging: a prospective study. Radiology. 2009 Sep;252(3):721-8. doi: 10.1148/radiol.2523082090.</citation>
    <PMID>19567650</PMID>
  </results_reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2007</study_first_submitted>
  <study_first_submitted_qc>December 17, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2007</study_first_posted>
  <last_update_submitted>November 2, 2016</last_update_submitted>
  <last_update_submitted_qc>November 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>magnetic resonance imaging</keyword>
  <keyword>renal function</keyword>
  <keyword>renal transplant</keyword>
  <keyword>urinary calculi</keyword>
  <keyword>healthy controls</keyword>
  <keyword>kidney</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calculi</mesh_term>
    <mesh_term>Urinary Calculi</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

